Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia

Journal of Psychiatric Research

Volumn 45, Issue 3, 2011, Pages 339-346

  Siegmund, Anja ^a   Köster, Luisa ^a   Meves, Anna M ^a   Plag, Jens ^a   Stoy, Meline ^a   Ströhle, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ACTH; CBT; Cortisol; Exposure; Prediction; Situation induced

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; STRESS HORMONE;

AGORAPHOBIA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEAR; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; IN VIVO STUDY; MALE; NEUROTRANSMISSION; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOTHERAPY; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGORAPHOBIA; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COGNITIVE THERAPY; FEAR; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RADIOIMMUNOASSAY; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 79951553580     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.07.002     Document Type: Article

References (41)

1. Abelson J.L., Curtis G.C. Cardiac and neuroendocrine responses to exposure therapy in height phobics: desynchrony within the 'physiological response system'. Behaviour Research and Therapy 1989, 27:561-567.
2. Abelson J.L., Khan S., Liberzon I., Young E.A. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007, 24:66-76.
3. Alpers G.W., Abelson J.L., Wilhelm F.H., Roth W.T. Salivary cortisol response during exposure treatment in driving phobics. Psychosomatic Medicine 2003, 65:679-687.
4. Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. International Clinical Psychopharmacology 1995, 10:73-81.
5. Bandelow B., Wedekind D., Pauls J., Broocks A., Hajak G., Ruther E. Salivary cortisol in panic attacks. American Journal of Psychiatry 2000, 157:454-456.
6. Barrett D., Gonzalez-Lima F. Behavioral effects of metyrapone on Pavlovian extinction. Neuroscience Letters 2004, 371:91-96.
7. Beck A.T., Steer R.A. Manual for the revised beck depression inventory 1988, The Psychological Corporation, San Antonio: TX.
8. Beck A.T., Steer R.A. Beck anxiety inventory 1993, The Psychological Corporation, San Antonio: TX.
9. Bohus B. Central nervous structures and the effect of ACTH and corticosteroids on avoidance behavior: a study with intracerebral inplantation of corticosteroids in the rat. Progress in Brain Research 1970, 32:171-184.
10. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., Herman J.P. Dissociation of ACTH and glucocorticoids. Trends in Endocrinology and Metabolism 2008, 19:175-180.
11. Bouton M.E., Mineka S., Barlow D.H. A modern learning theory perspective on the etiology of panic disorder. Psychological Review 2001, 108:4-32.
12. Cameron O.G., Lee M.A., Curtis G.C., McCann D.S. Endocrine and physiological changes during " spontaneous" panic attacks. Psychoneuroendocrinology 1987, 12:321-331.
13. Chambless D.L., Caputo G.C., Jasin S.E., Gracely E.J., Williams C. The mobility inventory for agoraphobia. Behaviour Research and Therapy 1985, 23:35-44.
14. Coryell W., Noyes R., Reich J. The prognostic significance of HPA-axis disturbance in panic disorder: a three-year follow-up. Biological Psychiatry 1991, 29:96-102.
15. Curtis G., Buxton M., Lippman D., Nesse R., Wright J. " Flooding in vivo" during the circadian phase of minimal cortisol secretion: anxiety and therapeutic success without adrenal cortical activation. Biological Psychiatry 1976, 11:101-107.
16. Curtis G.C., Nesse R., Buxton M., Lippman D. Anxiety and plasma cortisol at the crest of the circadian cycle: reappraisal of a classical hypothesis. Psychosomatic Medicine 1978, 40:368-378.
17. de Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Frontier Neuroendocrinology 1991, 12:95-164.
18. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychological Bulletin 2004, 130:355-391.
19. Garcia-Leal C., Parente A.C., Del Ben C.M., Guimaraes F.S., Moreira A.C., Elias L.L., et al. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Research 2005, 133:239-252.
20. Graeff F.G., Garcia-Leal C., Del Ben C.M., Guimaraes F.S. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?. Anais da Academia Brasileira de Ciências 2005, 77:477-491.
21. Holsboer F., von Bardeleben U., Buller R., Heuser I., Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Hormone and Metabolic Research 1987, 16:80-88.
22. Joels M., de Kloet E.R. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 1989, 245:1502-1505.
23. Joels M., de Kloet E.R. Control of neuronal excitability by corticosteroid hormones. Trends in Neurosciences 1992, 15:25-30.
24. Kellner M., Herzog L., Holsboer F., Wiedemann K. A possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. American Journal of Psychiatry 1995, 152:1365-1367.
25. Kellner M., Schick M., Yassouridis A., Struttmann T., Wiedemann K., Alm B. Metyrapone tests in patients with panic disorder. Biological Psychiatry 2004, 56:898-900.
26. Kovacs G.L., Teledgdy G., Lissak K. 5-hydroxytryptamine and the mediation of pituitary-adrenocortical hormones in the extinction of active avoidance behaviour. Psychoneuroendocrinology 1976, 1:219-230.
27. Margraf J., Schneider S. Panik. Angstanfälle und ihre Behandlung 1990, Springer, Berlin.
28. McGaugh J.L., Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Current Opinion in Neurobiology 2002, 12:205-210.
29. McGaugh J.L., Roozendaal B. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl) 2009, 202:3-14.
30. Mineka S., Zinbarg R. Conditioning and ethological models of anxiety disorders: stress-in-dynamic-context anxiety models. Nebraska Symposium on Motivation (Series) 1996, 43:135-210.
31. Mowrer O.H. A stimulus-response analysis of anxiety and its role as a reinforcing agent. Psychological Review 1939, 46:553-565.
32. Myers K.M., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12:120-150.
33. Nesse R.M., Curtis G.C., Thyer B.A., McCann D.S., Huber-Smith M.J., Knopf R.F. Endocrine and cardiovascular responses during phobic anxiety. Psychosomatic Medicine 1985, 47:320-332.
34. Petrowski K., Herold U., Joraschky P., Wittchen H.U., Kirschbaum C. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 2010, 35:414-421.
35. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.-C. Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 1996, 15:7-15.
36. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 20(59 Suppl):22-33.
37. Shors T.J., Levine S., Thompson R.F. Effect of adrenalectomy and demedullation on the stress-induced impairment of long-term potentiation. Neuroendocrinology 1990, 51:70-75.
38. Strohle A., Kellner M., Holsboer F., Wiedemann K. Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test. Biological Psychiatry 1998, 43:371-375.
39. Woods S.W., Charney D.S., McPherson C.A., Gradman A.H., Heninger G.R. Situational panic attacks. Behavioral, physiologic, and biochemical characterization. Archives of General Psychiatry 1987, 44:365-375.
40. Yang Y.L., Chao P.K., Lu K.T. Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 2006, 31:912-924.
41. Yehuda R., Boisoneau D., Mason J.W., Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biological Psychiatry 1993, 34:18-25.